Cargando…
Multidrug resistance circumvention by a new triazinoaminopiperidine derivative S9788 in vitro: definition of the optimal schedule and comparison with verapamil.
The current work was undertaken to investigate the importance of exposure sequence and duration in achieving the maximum reversal action of S9788 on doxorubicin (DOX) cytotoxicity against cells that exhibit the (MDR) multidrug resistance phenotype: the MCF7/DOX cell line. Accumulation and release of...
Autores principales: | Julia, A. M., Roché, H., Berlion, M., Lucas, C., Milano, G., Robert, J., Bizzari, J. P., Canal, P. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1994
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968895/ https://www.ncbi.nlm.nih.gov/pubmed/8180016 |
Ejemplares similares
-
Inherent adriamycin resistance in a murine tumour line: circumvention with verapamil and norverapamil.
por: Merry, S., et al.
Publicado: (1989) -
Resistance of human glioma to adriamycin in vitro: the role of membrane transport and its circumvention with verapamil.
por: Merry, S., et al.
Publicado: (1986) -
Circumvention of drug resistance in human non-small cell lung cancer in vitro by verapamil.
por: Merry, S., et al.
Publicado: (1987) -
Phase IB study of doxorubicin in combination with the multidrug resistance reversing agent S9788 in advanced colorectal and renal cell cancer.
por: Punt, C. J., et al.
Publicado: (1997) -
Circumvention of Atypical Multidrug Resistance with Tumor Necrosis Factor
por: Cimoli, Guido, et al.
Publicado: (1994)